Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity

International Journal of Cancer

Volumn 82, Issue 2, 1999, Pages 293-297

  Blackburn, Robert V ^a   Galoforo, Sandra S ^a   Corry, Peter M ^a   Lee, Yong J ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FUSION GENE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIOSENSITIVITY;

ADENOVIRIDAE; ANIMALS; ANTIMETABOLITES; ANTIMETABOLITES, ANTINEOPLASTIC; ANTIVIRAL AGENTS; CARCINOMA; CYTOMEGALOVIRUS; CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENETIC VECTORS; HUMANS; MALE; NUCLEOSIDE DEAMINASES; PRODRUGS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RATS; RECOMBINANT FUSION PROTEINS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0033016278     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990719)82:2<293::AID-IJC22>3.0.CO;2-H     Document Type: Article

References (20)

1. BLACKBURN, R.V., GALOFORO, S.S., BERNS, C.M., IRELAND, M., CHO, J.M., CORRY, P.M. and LEE, Y.J., Induction of thermal response in murine L929 cells lacking aB-crystallin expression and aB-crystallin expressing L929 transfectants. Mol. cell. Biochem., 155, 51-60 (1995).
2. BLACKBURN, R.V., GALOFORO, S.S., CORRY, P.M. and LEE, Y.J., Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells. Cancer Res., 58, 1358-1362 (1998).
3. CALABRESI, P. and CHABNER, B.A., Drug therapy: ganciclovir. In: A.G. Gilman, T. Ra, A.S. Nies and P. Taylor (eds.), Goodman and Gilman's The pharmacological basis of therapeutics (8th ed.), pp. 1209-1263, Pergamon Press, New York (1990).
4. CHEN, L., PERLICK, H. and MORGAN, R.A., Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX. Hum. Gene Ther., 8, 125-135 (1997).
5. CRUMPACKER, C.S., Drug therapy: ganciclovir. N. Engl. J. Med., 335, 721-729 (1996).
6. CRYSTAL, R.G., Transfer of genes to humans: early lessons and obstacles to success. Science, 270, 404-409 (1995).
7. DEONARAIN, M.P., SPOONER, R.A. and EPENETOS, A.A., Genetic delivery of enzymes for cancer therapy. Gene Ther., 2, 235-244 (1995).
8. FICK, J., BARKER, F.G., DAZIN, P., WESTPHALE, E.M., BEYER, E.C. and ISRAEL, M.A., The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc. nat. Acad. Sci. (Wash.), 92, 11071-11075 (1995).
9. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L. and ABRAHAM, G.N., The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53, 5274-5283 (1993).
10. GORZIGLIA, M.I., KADN, M.J., YEI, S., LIM, J., LEE, G.M., LUTHRA, R. and TRAPNEL, B.C., Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol., 70, 4173-4178 (1996).
11. GRAHAM, F.L. and PREVEC, L., Methods for construction of adenovirus vectors. Mol. Biotechnol., 3, 207-220 (1995).
12. GRAHAM, F.L. and VAN DER EB, A.J., A new technique for the assay of infectivity of adenovirus 5 DNA. Virology, 52, 456-467 (1973).
13. IMLER, J.L., Adenoviral vectors as recombinant viral vaccines. Vaccine, 13, 1143-1151 (1995).
14. KEYSER, D., KUPELIAN, P.A., ZIPPE, C.D., LEVIN, H.S. and KLEIN, E.A., Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/m1: radiation therapy or surgery? Int. J. Radiat. Oncol. Biol. Phys., 38, 723-729 (1997).
15. KINGSTON, R.E., Transfection of DNA into eukaryotic cells. In: F.M. Ausubel, R. Brent, R.E. Kingston, D.D, Moore, J.G. Seidman, J.A. Smith and K. Struhl (eds.), Short protocols in molecular biology, pp. 9-5, J. Wiley, New York (1992).
16. MOOLTEN, F.L., Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther., 1, 279-287 (1994).
17. PREVEC, L., SCHNEIDER, M., ROSENTHAL, K.L., BELBECK, L.W., DERBYSHIRE, J.B. and GRAHAM, F.L., Use of human adenovirus based vectors for antigen expression in animals. J. gen. Virol., 70, 429-434 (1989).
18. ROGULSKI, K.R., KIM, J.H., KIM, S.H. and FREYTAG, S.O., Glioma cells transduced with an Escherichia coli CD/HSV-I TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther., 8, 73-85 (1997).
19. ROTH, J.A. and CRISTIANO, R.J., Gene therapy for cancer: what have we done and where are we going? J. nat. Cancer Inst., 89, 21-39 (1997).
20. VINCINI, F.A., HORWITZ, E.M., GONZALEZ, J. and MARTINEZ, A.A., Treatment options for localized prostate cancer based on pretreatment serum prostate specific antigen levels. J. Urol., 158, 319-325 (1997).